Veeva offers quality suite that unifies quality processes, document control, and training to streamline quality management and audit-readiness
BARCELONA, Spain — 30 May 2018 — Veeva Systems (NYSE:VEEV) today announced Veeva Vault Training, a new cloud application to simplify role-based training across life sciences organizations and help quality teams remain audit-ready and compliant. Together with Veeva Vault QMS and Veeva Vault QualityDocs, Veeva will deliver a unified suite of quality applications on a single cloud platform that brings together training with quality processes and document control for seamless, end-to-end quality management.
“It’s time-consuming to manage and verify that the right people are trained,” said Beth Clarke, IT R&D global business partner at Halozyme. “Bringing quality management and training together would make it easier for individuals to stay current with the latest procedures and documents as they change.”
Quality teams are limited by manual training processes and fragmented systems that make it difficult to manage and track training and connect it to document change control or quality events. Vault Training will enable life sciences companies to easily and efficiently organize, assign, and track content and information so the right people are trained on policies and procedures. A centralized view of training across the organization provides full visibility into what content exists and who has achieved qualification to ensure job-readiness.
Because Vault Training is part of the Veeva Vault Quality Suite of unified applications, individuals can seamlessly access critical content managed in Vault QualityDocs to efficiently complete training tasks. Also, quality events within Vault QMS automatically trigger training tasks for complete traceability and transparency of new training requirements. This enables organizations to stay current on role-based qualifications as events happen and policies change and have greater control over training content, from creation and approval to trainee completion.
“Veeva will make it easier for users to get the training they need and help administrators ensure the right roles stay current with the latest quality documents and processes,” said Kent Malmros, senior director of Vault Training. “Now quality teams can more effectively manage and deliver workplace learning so their organizations remain compliant and audit-ready.”
Vault Training provides a validation-ready system for companies to manage compliance-related training, reducing validation times from months to days. Vault QMS, Vault QualityDocs, and Vault Training are part of the Vault Quality Suite. More than 150 customers use Vault Quality applications to manage their quality processes with greater visibility and control.
Veeva Vault Training is planned for availability in late 2018.
Learn more about Vault Training at the upcoming Veeva R&D Summit, Europe, which will showcase the latest innovations across quality, clinical, and regulatory in Barcelona, June 12-14, 2018. The annual gathering of more than 350 delegates is complimentary for Veeva customers and invited guests. Learn more and register at veeva.com/EUSummit.
For more on Veeva Vault Training, visit: veeva.com/eu/VaultTraining
Connect with Veeva on LinkedIn: linkedin.com/company/veeva-systems
Follow @Veeva_EU on Twitter: twitter.com/veeva_eu
Like Veeva on Facebook: facebook.com/veevasystems
About Veeva Systems
Veeva Systems Inc. is a leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva has more than 625 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs. Veeva is headquartered in the San Francisco Bay Area, with offices in Europe, Asia, and Latin America. For more information, visit veeva.com/eu.
This release contains forward-looking statements, including the market demand for and acceptance of Veeva’s products and services, the results from use of Veeva’s products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon Veeva’s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent Veeva’s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and Veeva disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect Veeva’s financial results are included under the captions, “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” in the company’s filing on Form 10-K for the period ended January 31, 2018. This is available on the company’s website at veeva.com under the Investors section and on the SEC’s website at sec.gov. Further information on potential risks that could affect actual results will be included in other filings Veeva makes with the SEC from time to time.